Holocene Advisors’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $449M | Buy |
4,181,034
+2,295,282
| +122% | +$247M | 1.1% | 13 |
|
2025
Q1 | $190M | Sell |
1,885,752
-1,171,948
| -38% | -$118M | 0.56% | 52 |
|
2024
Q4 | $273M | Sell |
3,057,700
-939,932
| -24% | -$84M | 0.87% | 19 |
|
2024
Q3 | $335M | Sell |
3,997,632
-42,798
| -1% | -$3.59M | 1.35% | 6 |
|
2024
Q2 | $311M | Sell |
4,040,430
-1,747,569
| -30% | -$135M | 1.3% | 9 |
|
2024
Q1 | $396M | Sell |
5,787,999
-2,097,160
| -27% | -$144M | 1.46% | 3 |
|
2023
Q4 | $456M | Buy |
7,885,159
+908,423
| +13% | +$52.5M | 1.78% | 3 |
|
2023
Q3 | $368M | Buy |
6,976,736
+904,969
| +15% | +$47.8M | 1.61% | 1 |
|
2023
Q2 | $328M | Buy |
6,071,767
+1,717,569
| +39% | +$92.9M | 1.4% | 6 |
|
2023
Q1 | $218M | Buy |
+4,354,198
| New | +$218M | 1.07% | 13 |
|
2022
Q4 | – | Sell |
-3,398,887
| Closed | -$132M | – | 695 |
|
2022
Q3 | $132M | Sell |
3,398,887
-182,781
| -5% | -$7.08M | 0.84% | 28 |
|
2022
Q2 | $133M | Sell |
3,581,668
-318,482
| -8% | -$11.9M | 0.81% | 35 |
|
2022
Q1 | $173M | Buy |
3,900,150
+619,103
| +19% | +$27.4M | 0.9% | 24 |
|
2021
Q4 | $139M | Buy |
3,281,047
+560,862
| +21% | +$23.8M | 0.73% | 38 |
|
2021
Q3 | $118M | Buy |
2,720,185
+77,740
| +3% | +$3.37M | 0.64% | 38 |
|
2021
Q2 | $113M | Sell |
2,642,445
-2,329,494
| -47% | -$99.6M | 0.64% | 38 |
|
2021
Q1 | $192M | Buy |
4,971,939
+4,454,432
| +861% | +$172M | 1.21% | 9 |
|
2020
Q4 | $18.6M | Sell |
517,507
-1,650,239
| -76% | -$59.3M | 0.12% | 194 |
|
2020
Q3 | $82.8M | Buy |
+2,167,746
| New | +$82.8M | 0.63% | 44 |
|
2019
Q4 | – | Sell |
-623,762
| Closed | -$25.4M | – | 664 |
|
2019
Q3 | $25.4M | Sell |
623,762
-133,079
| -18% | -$5.42M | 0.26% | 93 |
|
2019
Q2 | $32.5M | Buy |
+756,841
| New | +$32.5M | 0.41% | 72 |
|
2018
Q2 | – | Sell |
-20,986
| Closed | -$573K | – | 573 |
|
2018
Q1 | $573K | Buy |
20,986
+999
| +5% | +$27.3K | 0.01% | 180 |
|
2017
Q4 | $495K | Buy |
+19,987
| New | +$495K | 0.01% | 411 |
|